MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 246 filers reported holding MIRATI THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,488,376 | +35.2% | 240,780 | +12.1% | 0.00% | +100.0% |
| Q2 2023 | $7,759,206 | +2.5% | 214,758 | +5.5% | 0.00% | -50.0% |
| Q1 2023 | $7,570,108 | -13.9% | 203,607 | +4.9% | 0.00% | 0.0% |
| Q4 2022 | $8,791,635 | -36.3% | 194,033 | -1.8% | 0.00% | -33.3% |
| Q3 2022 | $13,795,000 | +7.2% | 197,519 | +3.0% | 0.00% | 0.0% |
| Q2 2022 | $12,872,000 | -21.8% | 191,737 | -4.2% | 0.00% | 0.0% |
| Q1 2022 | $16,462,000 | -43.4% | 200,214 | +0.9% | 0.00% | -40.0% |
| Q4 2021 | $29,107,000 | -13.3% | 198,430 | +4.6% | 0.01% | -16.7% |
| Q3 2021 | $33,561,000 | -10.7% | 189,701 | -18.5% | 0.01% | -14.3% |
| Q2 2021 | $37,582,000 | -53.8% | 232,660 | -51.0% | 0.01% | -53.3% |
| Q1 2021 | $81,362,000 | -25.2% | 474,970 | -4.1% | 0.02% | -28.6% |
| Q4 2020 | $108,738,000 | +47.7% | 495,072 | +11.7% | 0.02% | +31.2% |
| Q3 2020 | $73,610,000 | +39.4% | 443,297 | -4.1% | 0.02% | +23.1% |
| Q2 2020 | $52,790,000 | +80.4% | 462,378 | +21.5% | 0.01% | +62.5% |
| Q1 2020 | $29,264,000 | -34.5% | 380,711 | +9.8% | 0.01% | -20.0% |
| Q4 2019 | $44,666,000 | +60.8% | 346,628 | -2.8% | 0.01% | +42.9% |
| Q3 2019 | $27,783,000 | -9.8% | 356,615 | +19.3% | 0.01% | 0.0% |
| Q2 2019 | $30,785,000 | +43.8% | 298,884 | +2.3% | 0.01% | +40.0% |
| Q1 2019 | $21,408,000 | +83.9% | 292,066 | +6.4% | 0.01% | +66.7% |
| Q4 2018 | $11,643,000 | -9.5% | 274,475 | +0.5% | 0.00% | 0.0% |
| Q3 2018 | $12,860,000 | +5.4% | 273,031 | +10.3% | 0.00% | 0.0% |
| Q2 2018 | $12,203,000 | +558.9% | 247,532 | +310.2% | 0.00% | – |
| Q1 2018 | $1,852,000 | +84.1% | 60,341 | +9.4% | 0.00% | – |
| Q4 2017 | $1,006,000 | +61.0% | 55,144 | +3.3% | 0.00% | – |
| Q3 2017 | $625,000 | +285.8% | 53,401 | +20.4% | 0.00% | – |
| Q2 2017 | $162,000 | -81.9% | 44,365 | -74.2% | 0.00% | – |
| Q1 2017 | $894,000 | +32.8% | 172,034 | +21.4% | 0.00% | – |
| Q4 2016 | $673,000 | -30.3% | 141,665 | -3.1% | 0.00% | – |
| Q3 2016 | $966,000 | +15.1% | 146,142 | -4.9% | 0.00% | – |
| Q2 2016 | $839,000 | -72.5% | 153,684 | +7.7% | 0.00% | -100.0% |
| Q1 2016 | $3,055,000 | -29.9% | 142,747 | +3.6% | 0.00% | 0.0% |
| Q4 2015 | $4,355,000 | -0.3% | 137,833 | +8.6% | 0.00% | 0.0% |
| Q3 2015 | $4,370,000 | +63.6% | 126,940 | +49.6% | 0.00% | 0.0% |
| Q2 2015 | $2,671,000 | +31.1% | 84,871 | +22.1% | 0.00% | 0.0% |
| Q1 2015 | $2,038,000 | +74.9% | 69,531 | +10.5% | 0.00% | – |
| Q4 2014 | $1,165,000 | +4.0% | 62,938 | -1.6% | 0.00% | – |
| Q3 2014 | $1,120,000 | – | 63,972 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |